Prof. Rosati obtained a degree in Pharmacy from the University of Salerno in 2002. Subsequently, she obtained a Ph.D. in Biochemistry and Pathology of Drug Action, completed in 2007. Prof. Rosati’s primary area of interest lies in understanding the intricate relationships involving the BAG3 protein. She has explored BAG3’s interactions with various other proteins, including NF-kB, WT-1, Btk, and more. Her research extends to unraveling the role of BAG3 in different disorders, such as viral infections, cancer, inflammation, and fibrosis. Prof. Rosati has successfully collaborated with esteemed institutions worldwide, including the University of California (San Diego), Temple University, University of Utah, Harvard Medical School, University of Amsterdam, University of Verona, and University of Chieti-Pescara. She actively participated in organizing committees for international pancreatic cancer congresses from 2008 to 2014. Prof. Rosati served as Guest Editor for a special edition of the Journal of Cellular Biochemistry titled “The co-chaperone BAG3: Orchestrator of the cellular task force in response to stress.” Additionally, she played a pivotal role in academic spin-off initiatives and was involved in drafting and submitting eight local and international patent applications (including BIOUNIVERSA in 2009 and FIBROSYS in 2021). Her ongoing research efforts are centered around characterizing and developing antibodies for both therapeutic and diagnostic purposes.
Prof. Rosati obtained a degree in Pharmacy from the University of Salerno in 2002. Subsequently, she obtained a Ph.D. in Biochemistry and Pathology of Drug Action, completed in 2007. Prof. Rosati’s primary area of interest lies in understanding the intricate relationships involving the BAG3 protein. She has explored BAG3’s interactions with various other proteins, including NF-kB, WT-1, Btk, and more. Her research extends to unraveling the role of BAG3 in different disorders, such as viral infections, cancer, inflammation, and fibrosis. Prof. Rosati has successfully collaborated with esteemed institutions worldwide, including the University of California (San Diego), Temple University, University of Utah, Harvard Medical School, University of Amsterdam, University of Verona, and University of Chieti-Pescara. She actively participated in organizing committees for international pancreatic cancer congresses from 2008 to 2014. Prof. Rosati served as Guest Editor for a special edition of the Journal of Cellular Biochemistry titled “The co-chaperone BAG3: Orchestrator of the cellular task force in response to stress.” Additionally, she played a pivotal role in academic spin-off initiatives and was involved in drafting and submitting eight local and international patent applications (including BIOUNIVERSA in 2009 and FIBROSYS in 2021). Her ongoing research efforts are centered around characterizing and developing antibodies for both therapeutic and diagnostic purposes.